Drugs Made In America Acquisition II Corp.

Drugs Made In America Acquisition II Corp. (Nasdaq: DMII) is a blank-check company targeting the pharmaceutical and domestic drug manufacturing sector, and represents a follow-on vehicle in the Drugs Made In America SPAC family. The company filed an 8-K with the Securities and Exchange Commission on April 3, 2026, accession number 0001213900-26-039986, reflecting continued corporate activity as the vehicle pursues a business combination. DMII is part of a cohort of SPACs oriented toward U.S. life-sciences and pharmaceutical supply-chain opportunities. For full sponsor details, IPO date, deal status, and real-time filing alerts on DMII, create a free account at SpacDesk.